These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24674882)

  • 1. B cell transcription factors: Potential new therapeutic targets for SLE.
    De S; Barnes BJ
    Clin Immunol; 2014; 152(1-2):140-51. PubMed ID: 24674882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cell biology: implications for treatment of systemic lupus erythematosus.
    Anolik JH
    Lupus; 2013 Apr; 22(4):342-9. PubMed ID: 23553777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunological basis of B-cell therapy in systemic lupus erythematosus.
    Mok MY
    Int J Rheum Dis; 2010 Feb; 13(1):3-11. PubMed ID: 20374380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant B cell selection and activation in systemic lupus erythematosus.
    Kil LP; Hendriks RW
    Int Rev Immunol; 2013 Aug; 32(4):445-70. PubMed ID: 23768157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cells biology in systemic lupus erythematosus-from bench to bedside.
    Zhao L; Ye Y; Zhang X
    Sci China Life Sci; 2015 Nov; 58(11):1111-25. PubMed ID: 26563177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do naturally occurring autoantibodies participate in the constitution of the pathological B-cell repertoire in systemic lupus erythematosus?
    Gilbert D; Brard F; Jovelin F; Tron F
    J Autoimmun; 1996 Apr; 9(2):247-57. PubMed ID: 8738970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid-induced leucine zipper (GILZ) inhibits B cell activation in systemic lupus erythematosus.
    Jones SA; Toh AE; Odobasic D; Oudin MA; Cheng Q; Lee JP; White SJ; Russ BE; Infantino S; Light A; Tarlinton DM; Harris J; Morand EF
    Ann Rheum Dis; 2016 Apr; 75(4):739-47. PubMed ID: 26612340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell biology and dysfunction in SLE.
    Anolik JH
    Bull NYU Hosp Jt Dis; 2007; 65(3):182-6. PubMed ID: 17922667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding B-cell activation and autoantibody repertoire selection in systemic lupus erythematosus: A B-cell immunomics approach.
    Tipton CM; Hom JR; Fucile CF; Rosenberg AF; Sanz I
    Immunol Rev; 2018 Jul; 284(1):120-131. PubMed ID: 29944759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.
    Dörner T
    J Rheumatol Suppl; 2006 May; 77():3-11. PubMed ID: 16652439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity.
    Moulton VR; Tsokos GC
    J Clin Invest; 2015 Jun; 125(6):2220-7. PubMed ID: 25961450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of apoptosis in autoimmunity: immunogen, antigen, and accelerant.
    Levine JS; Koh JS
    Semin Nephrol; 1999 Jan; 19(1):34-47. PubMed ID: 9952279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective B cell tolerance checkpoints in systemic lupus erythematosus.
    Yurasov S; Wardemann H; Hammersen J; Tsuiji M; Meffre E; Pascual V; Nussenzweig MC
    J Exp Med; 2005 Mar; 201(5):703-11. PubMed ID: 15738055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging and critical issues in the pathogenesis of lupus.
    Gatto M; Zen M; Ghirardello A; Bettio S; Bassi N; Iaccarino L; Punzi L; Doria A
    Autoimmun Rev; 2013 Feb; 12(4):523-36. PubMed ID: 23000207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T follicular helper (Tfh) cells in lupus: Activation and involvement in SLE pathogenesis.
    Blanco P; Ueno H; Schmitt N
    Eur J Immunol; 2016 Feb; 46(2):281-90. PubMed ID: 26614103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinations of B cell fate in immunity and autoimmunity.
    Noelle RJ; Erickson LD
    Curr Dir Autoimmun; 2005; 8():1-24. PubMed ID: 15564715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
    Liang B; Gardner DB; Griswold DE; Bugelski PJ; Song XY
    Immunology; 2006 Nov; 119(3):296-305. PubMed ID: 17067309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulators of B-cell activity in SLE: a better target for treatment than B-cell depletion?
    Dolff S; Abdulahad WH; Bijl M; Kallenberg CG
    Lupus; 2009 Jun; 18(7):575-80. PubMed ID: 19433456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ets-1: a new player in the pathogenesis of systemic lupus erythematosus?
    Pan HF; Leng RX; Tao JH; Li XP; Ye DQ
    Lupus; 2011 Mar; 20(3):227-30. PubMed ID: 21362749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell tolerance checkpoints in health and autoimmunity.
    Meffre E; Wardemann H
    Curr Opin Immunol; 2008 Dec; 20(6):632-8. PubMed ID: 18848883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.